Exosomal KRAS status could predict disease progression with sensitivity and specificity of 75.4% and 92.6% respectively, with a positive exosomal KRAS result indicating an 8.17 times greater probability of having localized pancreatic cancer (Table 1). The gene discussed is KRAS; the disease is pancreatic neoplasm.